First patient dosed in Phase Ib Pompe disease trial
Aro Biotherapeutics has dosed the first patient in a Phase Ib trial of ABX1100, a novel treatment for late-onset Pompe …
Post
-
-
Testosterone can predict cardiometabolic disease in men with erectile dysfunction
A recent study published in Sexual Medicine from the Kaohsiung Armed Forces General Hospital in Taiwan aimed to determine whether …
-
Bladder cancer: Shaping the future of global clinical trials
Bladder cancer remains a formidable health challenge, ranking as the ninth most common cancer worldwide and the thirteenth leading cause …
-
Intellia doses first subject in trial of NTLA-2002 for hereditary angioedema
Intellia Therapeutics has dosed the first subject in a randomised, placebo-controlled global Phase III trial of its investigational CRISPR-based therapy, …
-
Lindus Health completes $55m funding round
Self-described anti-clinical research organisation (CRO) Lindus Health has received $55m in Series B funding to back its fully integrated, AI-driven …
-
Rigel enrols first subject in Phase I sickle cell disease therapy trial
Rigel Pharmaceuticals has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, …
-
Tris Pharma reports positive data from Phase III acute pain therapy trial
Tris Pharma has reported positive topline outcomes from its ALLEVIATE-1 Phase III trial of cebranopadol for treating moderate-to-severe acute pain …
-
Interim data success for Salubris Biotherapeutics’ heart failure candidate
US company Salubris Biotherapeutics (SalubrisBio) has seen its heart failure therapy, JK07, achieve some success in interim results taken from …
-
Sonnet BioTherapeutics to expand trial of SON-1010 with trabectedin for solid tumours
US-based biotechnology company Sonnet BioTherapeutics has expanded its Phase I SB101 study of SON-1010 for advanced solid tumours. The company is …
-
Exact Sciences post positive results from MRD trial
Exact Sciences, has shared results from a trial of its Oncodetect test which is designed to identify the last remaining …
-
Advarra introduces Study Collaboration to help improve trial partnership
US-based clinical research company Advarra has introduced Study Collaboration, a solution designed to expedite study startup by automating workflows. The solution …
-
The next stage of DCTs: New survey sheds light on how to move forward with mobile visits
Mobile research models are making a positive difference in clinical research, helping drug sponsors bring studies to patient populations that …
-
FDA lifts hold on Opella’s trial to support switch of Cialis to OTC drug
The US Food and Drug Administration (FDA) has removed the clinical hold on a trial of Cialis (tadalafil) by Sanofi's …
-
How biotechs can recover VAT on EU-based clinical trials
At a time when companies are managing more expensive clinical trials with less funding, any opportunity to reduce trial costs …
-
FDA lifts clinical hold on Amylyx’s Phase I ALS trial
The US Food and Drug Administration (FDA) has lifted a clinical hold on Amylyx Pharmaceuticals’ Phase I trial of AMX0114 …
